Medicine and Dentistry
Lupus Nephritis
100%
Systemic Lupus Erythematosus
80%
Pediatrics
34%
Lupus Erythematosus
28%
Biological Marker
25%
Rheumatology
22%
Renal Biopsy
22%
Disease
20%
End Stage Renal Disease
18%
Nephropathy
17%
Diagnosis
15%
Keratinocyte
15%
Proteinuria
14%
Arthritis
14%
Transcriptomics
14%
Biopsy
14%
Idiopathic Pulmonary Fibrosis
13%
Fibrosis
13%
Adolescent
11%
Blood Pressure Monitoring
10%
Pediatric Nephrology
10%
Cyclophosphamide
10%
Blood Pressure
10%
Nephritic Syndrome
9%
Chronic Kidney Disease
9%
Kidney Injury
9%
RNA Sequence
9%
Disease Activity
8%
Hydroxychloroquine
8%
Creatinine
8%
Nephrologist
8%
Rituximab
8%
Scar Formation
8%
Pediatrics Patient
7%
DNA Antibody
7%
Ambulatory Blood Pressure
7%
Disease Exacerbation
7%
Echocardiography
7%
Cystic Disease of the Kidney
6%
Membranous Glomerulonephritis
6%
Interferon Type I
6%
Medicine
6%
Renal Tubule
6%
Complement Membrane Attack Complex
6%
Polycystic Kidney Disease
6%
Hypertension
6%
Acute Liver Failure
6%
Liver Support
6%
COVID-19
6%
Cohort Analysis
6%
Keyphrases
Lupus Nephritis
40%
Childhood-onset SLE
13%
Kidney Disease
9%
Keratinocytes
9%
Pediatric Nephrologist
9%
Single-cell RNA Sequencing (scRNA-seq)
9%
Pediatric Rheumatologist
7%
Lupus
7%
Rheumatologists
6%
International childhoods
6%
Pristane-induced Lupus
6%
Surnames
6%
Single-cell Transcriptomics
6%
Tubular Cells
6%
Renal Scarring
6%
Anti-DNA Antibodies
6%
Acute Liver Failure
6%
BAFF-R
6%
Extracorporeal Liver Support
6%
CNS Involvement
6%
Pediatric Lupus
6%
COVID-19
6%
Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)
6%
Rituximab
6%
Molecular Heterogeneity
6%
Bile Duct Diseases
6%
Lupus Low Disease Activity State (LLDAS)
6%
Type I Interferon
6%
Urine microRNAs
6%
Renal Flare
6%
Kidney Involvement
6%
Tubular Injury
6%
Fibrosis
6%
Acute Glomerulonephritis
6%
Molecular Adsorbent Recirculating System
6%
Pediatric
6%
Nephrologists
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lupus Erythematosus Nephritis
34%
Disease
26%
Biological Marker
22%
Systemic Lupus Erythematosus
21%
Kidney Polycystic Disease
20%
End Stage Renal Disease
11%
Nephritis
9%
Inflammation
8%
DNA Antibody
8%
Scar Formation
8%
Hydroxychloroquine
8%
Mouse
6%
Interferon Type I
6%
B Cell Activating Factor Receptor
6%
Fibrosis
6%
Neutrophil Gelatinase Associated Lipocalin
6%
Kidney Disease
5%